Back

Empirical Marshall vein ethanol infusion as the first-line strategy in patients with persistent atrial fibrillation undergoing mitral isthmus ablation

27 August 2023 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Insights into catheter ablation of non-paroxysmal atrial fibrillation Catheter Ablation of Arrhythmias ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Xianfeng Du

Ningbo First Hospital, Ningbo (China)

8 More presentations in this session

Presentation thumbnail
Optimal cutoff duration of history or persistence of atrial fibrillation to undergo radiofrequency catheter ablation of longstanding atrial fibrillation
Doctor Y. Egami (Sakai, JP)
Abstract Slides Video
Presentation thumbnail
The impact of extensive ablation strategy for persistent atrial fibrillation on left atrial function and cardiovascular events: Insights from EARNEST-PVI randomized controlled trial
Doctor T. Oka (Suita, JP)
Abstract Slides Video
Presentation thumbnail
New mapping for determination of left atrial posterior wall isolation for non-paroxysmal atrial fibrillation
Doctor A. Suzuki (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Acute termination as an endpoint in individualised electrophysiological substrate ablation in persistent atrial fibrillation
Doctor A. Sharp (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Relationship between pre-procedural non-ischemic ST-segment depression and the clinical outcomes after catheter ablation in persistent atrial fibrillation patients
Doctor M. Yano (Sakai, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Insights into catheter ablation of non-paroxysmal atrial fibrillation

The Event

Event poster

ESC Congress 2023

27 August 2023 09:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources